Epitinib succinate

• Description:

  Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  548.59

• Molecular Formula:

  C28H32N6O6

• Notes:

  Research use only, not for human use.

• Receptor:

  Lysosomal acid lipase

• CAS Number:

  2252334-12-4